Clinical Trials Logo

Clinical Trial Summary

This is a phase 2, single-center, single-arm, open-label trial. Simon's two-stage design is performed to evaluate the efficacy of low-dose Decitabine in refractory aplastic anemia.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04854889
Study type Interventional
Source Institute of Hematology & Blood Diseases Hospital
Contact Jun Shi, PhD
Phone +8613752253515
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date May 1, 2021
Completion date March 31, 2025